Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

The Different Facets of Liquid Biopsy: A Kaleidoscopic View

Abstract : The current limitations of cancer diagnosis and molecular profiling based on invasive tissue biopsies or clinical imaging have led to the development of the liquid biopsy field. Liquid biopsy includes the isolation of circulating tumor cells (CTCs), circulating free or tumor DNA (cfDNA or ctDNA), extracellular vesicles (EVs), and tumor-educated platelets (TEPs) from body fluid samples and their molecular characterization to identify biomarkers for early cancer diagnosis, prognosis, therapeutic prediction, and follow-up. These innovative biosources show similar features as the primary tumor from where they originated or interacted. This review describes the different technologies and methods used for processing these biosources as well as their main clinical applications with their advantages and limitations.
Liste complète des métadonnées
Contributeur : Cécile Nowak <>
Soumis le : jeudi 30 avril 2020 - 09:30:24
Dernière modification le : vendredi 15 mai 2020 - 12:22:08




Zahra Eslami-S, Luis Enrique Cortés-Hernández, Laure Cayrefourcq, Catherine Alix-Panabières. The Different Facets of Liquid Biopsy: A Kaleidoscopic View. Cold Spring Harbor Perspectives in Medicine, Cold Spring Harbor Laboratory Press, In press, pp.a037333. ⟨10.1101/cshperspect.a037333⟩. ⟨hal-02559000⟩



Consultations de la notice